GeneDx (WGS) PT Raised at Piper Sandler; 'We Recommend Buying More on a Pullback'
Tweet Send to a Friend
Piper Sandler analyst David Westenberg raised the price target on GeneDx (NASDAQ: WGS) to $140.00 (from $120.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
